cilostazol has been researched along with Osteoarthritis, Knee in 1 studies
Osteoarthritis, Knee: Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SW | 1 |
| Song, YS | 1 |
| Shin, SH | 1 |
| Kim, KT | 1 |
| Park, YC | 1 |
| Park, BS | 1 |
| Yun, I | 1 |
| Kim, K | 1 |
| Lee, SY | 1 |
| Chung, WT | 1 |
| Lee, HJ | 1 |
| Yoo, YH | 1 |
1 other study available for cilostazol and Osteoarthritis, Knee
| Article | Year |
|---|---|
Cilostazol protects rat chondrocytes against nitric oxide-induced apoptosis in vitro and prevents cartilage destruction in a rat model of osteoarthritis.
Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Cartilage, Articular; Casein Kinas | 2008 |